Stockscreener 앱 받기
4.85
1.02%
-0.05
시간 외 거래:
4.84
-0.010
-0.21%
전일 마감가:
$4.90
열려 있는:
$4.92
하루 거래량:
4.37M
Relative Volume:
0.64
시가총액:
$1.73B
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-12.44
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
+22.47%
1개월 성능:
+21.25%
6개월 성능:
+234.48%
1년 성능:
+512.22%
1일 변동 폭
$4.76
$5.00
1주일 범위
$3.74
$5.19
52주 변동 폭
$0.6513
$5.225
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.85 | 1.73B | 6.23M | -95.90M | -68.47M | -0.39 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Is Precigen Inc. stock supported by strong cash flowsQuarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
Precigen (PGEN) Q3 2025 Earnings Call Transcript - AOL.com
Will Precigen Inc. stock benefit from commodity pricesJuly 2025 Recap & Long-Term Safe Investment Ideas - newser.com
Using R and stats models for Precigen Inc. forecastingRisk Management & Weekly Top Performers Watchlists - newser.com
How Precigen Inc. stock performs in interest rate cyclesDay Trade & Technical Pattern Based Signals - newser.com
US High Growth Tech Stocks to Watch in November 2025 - simplywall.st
Vaxart, Precigen among biotech gainers after Q3 results - MSN
Is Now The Right Time To Watch Precigen's Commercial Launch Story? - RTTNews
Intraday pattern recognizer results for Precigen Inc.Quarterly Portfolio Report & Free Community Supported Trade Ideas - newser.com
Will Precigen Inc. stock benefit from AI adoptionPortfolio Profit Report & Technical Entry and Exit Alerts - newser.com
Can technical indicators confirm Precigen Inc.’s reversalJuly 2025 Update & Daily Price Action Insights - newser.com
Using data tools to time your Precigen Inc. exit2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
What’s the recovery path for long term holders of Precigen Inc.Trade Risk Assessment & AI Based Trade Execution Alerts - newser.com
Is Precigen Inc. stock in correction or buying zoneQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
What technical models suggest about Precigen Inc.’s comebackJuly 2025 WrapUp & Daily Profit Focused Stock Screening - newser.com
Strategies to average down on Precigen Inc.July 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
Can you recover from losses in Precigen Inc.Market Growth Review & Free Community Consensus Stock Picks - newser.com
How to integrate Precigen Inc. into portfolio analysis toolsTrade Risk Report & Reliable Entry Point Alerts - newser.com
Tools to assess Precigen Inc.’s risk profileTrade Analysis Summary & Safe Swing Trade Setups - newser.com
Is now a turning point for Precigen Inc.Market Trend Summary & Reliable Momentum Entry Alerts - newser.com
Applying chart zones and confluence areas to Precigen Inc.2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Precigen’s Optimistic Earnings Call Highlights Papcemias Success - TipRanks
HC Wainwright & Co. Maintains Precigen (PGEN) Buy Recommendation - Nasdaq
Precigen stock holds steady as Citizens reiterates $8 price target By Investing.com - Investing.com South Africa
Vaxart (VXRT) and Precigen (PGEN) Shares Surge on Strong Q3 Earnings - GuruFocus
Vaxart, Precigen gain after Q3 2025 results (VXRT) - Seeking Alpha
Commit To Buy Precigen At $3.50, Earn 27.1% Using Options - Nasdaq
Precigen, Inc. (NASDAQ:PGEN) Q3 2025 Earnings Call Transcript - Insider Monkey
Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9. - GuruFocus
Will Precigen Inc. stock gain from lower inflationJuly 2025 Review & Consistent Profit Focused Trading Strategies - Fundação Cultural do Pará
Precigen stock holds steady as Citizens reiterates $8 price target - Investing.com
Earnings call transcript: Precigen Q3 2025 sees revenue beat but EPS miss - Investing.com Nigeria
Precigen Reports Q3 2025 Results and PAPZIMEOS Launch - TipRanks
Decoding Precigen Inc (PGEN): A Strategic SWOT Insight - GuruFocus
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... - Yahoo Finance
Transcript : Precigen, Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.08%
0.19%
자본화:
|
볼륨(24시간):